All three benchmarks finished with double-digit monthly lossesThe Dow closed out March with a steep loss today, giving back triple-digit midday gains to finish 410 points lower. The blue-chip index locked up steepest quarterly drop in its 124-year history. The S&P and Nasdaq both joined the Dow in the red today, with bank stocks among the notable laggards. All three indexes locked up March with d...Read More
DocuSign is finishing the month out strong, and options players are paying attentionWhile a large portion of the broad market is still struggling to recuperate from this month's violent selloff, DocuSign Inc (NASDAQ:DOCU) has recovered from its mid-March plummet and then some. In fact, the equity broke through recent pressure at the $90 region to nab a new all-time high of $98.38 earlier today, an...Read More
Major Indexes are in the black middayThe Dow Jones Industrial Average (DJI) is fighting toward a close in positive territory, in what's on track to be its worst quarter ever. The blue chip is fending off this morning's triple-digit drop before the bell, while both the Nasdaq Composite (IXIC) and S&P 500 Index (SPX) are also modestly in the black. Some traders speculate on a buying boost due to t...Read More
Sea is experiencing growth as consumers resort to online buyingE-commerce developer Sea Ltd. (NYSE:SE) is no stranger to the volatile broad market, but the equity has several layers of support in place that have helped push it higher during the past few months. A recent pullback was captured by SE's 200-day moving average. In fact, SE has been a major outperformer, boasting a year-to-date gain of...Read More
Amarin just lost a major U.S. patent lawsuit for its heart drug Vascepa On the charts, things are looking pretty bleak for Amarin Corporation plc (NASDAQ:AMRN) right now. The equity is down 68.4% at $4.29 during its first hour of trading -- on pace for its worst day in over 2 years -- after the biotech company lost a major U.S. patent lawsuit for its heart drug Vascepa, with Amarin initially claim...Read More
J.P. Morgan Securities and Cowen and Company cut their price targetsRH (NYSE: RH), formerly known as Restoration Hardware, is down 11.8% to trade at $104 this morning. The company reported fourth-quarter profits of $3.72 per share, higher than Wall Street's estimated $3.59 per share. Despite this, the revenue announced by the retailer was lower than anticipated, coming in at $664.98 million, the f...Read More
Lack of consumer spending is leading to V's projected low revenue growthAs the coronavirus pandemicwreaks havoc on the global economy, Visa Inc (NYSE:V) announced its transaction volumes have taken a major hit, as consumer spending falls off sharply. Additionally, the company forecastsingle-digit percentage revenue growth for the second quarter, which prompted price-target cuts from Instinet and S...Read More
The blue chip index is looking at it's worst first quarter on record, too It's not looking good for Dow Jones Industrial Average (DJI) futures this morning, which are eyeing a triple-digit drop coming into today's trading. Not only that, the blue-chip index is pacing for its worst first quarter ever, down roughly 21.8% coming into today. Futures on the Nasdaq-100 Index (NDX) and S&P 500 Index...Read More
(Adds recent repo program)By Jonnelle MarteMarch 31 (Reuters) - The Federal Reserve has moved intooverdrive to try to keep the U.S. economy from suffering lastingdamage from the coronavirus pandemic, announcing an emergencyinterest rate cut on March 3 and rolling out new efforts almostweekly since, including slashing rates to zero and relaunchinglarge-scale asset purchases.The U.S. central bank, a...Read More
The question everyone is asking: is the market meltdown over? If you watched nothing other than mainstream news you might be inclined to think that we have come through the storm and are ready to pick up the pieces, board the rocket ship, and launch the markets back to the stars. Mike Maloney begs to differ. Join him in this latest update as he shows why he believes we are in either a dead cat bou...Read More
Jim Grant, founder and editor of Grant's Interest Rate Observer, joins "Squawk Box" by phone to discuss the Fed's moves in the wake of the coronavirus pandemic.James "Jim" Grant is an American writer and publisher and the founder of Grant's Interest Rate Observer, a twice-monthly journal of the financial markets. He is the author , most recently, of The Forgotten Depression: 1921: The Crash That C...Read More
Mohamed El-Erian, chief economic advisor at Allianz, joins "Squawk Box" by phone to discuss the markets as well as the Fed action to try to lift the economy amid the coronavirus-driven slowdown.Mohamed El-Erian is the Chief Economic Adviser of Allianz, a multinational financial services company. He is the former CEO and co-Chief Investment Officer of PIMCO, a global investment firm and one of the...Read More
Harley Schlanger's work can be found at LaRouchePAC.com.Lior Gantz has been called a thrill-seeking entrepreneur by his team, and as such, he built and runs numerous successful businesses, and has traveled to over 30 countries in the past decade in pursuit of thrills and opportunities, gaining valuable knowledge and experience. With Wealth Research Group, Lior allows readers access into the world...Read More
The moves in the gold market during the past month have been insane. We've seen a false breakout, a crash and then a false breakdown. It all comes down to where you close the period. The fact that gold rallied back to its pre-crash peak is quite encouraging. It recovered all of its losses and got back to its previous point. Therefore, that's reason for great optimism. While the volatility has made...Read More
"His reckless disregard for human life put hundreds of people in his congregation at risk...as well as put thousands of residents who may interact with them in danger."Continue...Read More
People should not be expect the coronavirus crisis to blow over soon. "If we stop then all of our efforts will be wasted and we could potentially see a second peak. So over time, probably over the next six months, we will have a three-week review."Continue...Read More
"The economy? We have no economy. There is no economy...and yet stocks rally?!"Gregory Mannarino started his financial career working for the securities and trading arm of the now defunct Bear Stearns before the dot-com bubble. He is an active trader of the capital markets and has published several books pertaining to finance, global economics, and equity trading; His most recent book is titled Ul...Read More
Mickey Fulp the Mercenary Geologist sits down with Maurice Jackson of Proven and Probable to discuss the pernicious erosion of the Bill of Rights as both federal government and municipalities expand their footprint through their social and economic responses to the Wuhan Flu. We will discuss the euphemism's to Marital Law such as social distancing, self-isolation,shelter in place, and the impacts...Read More
Jordan Roy-Byrne joins me to recap this month for gold, silver, and gold stocks. Looking at the monthly charts we have huge candlesticks which correlate to a failed breakout and a failed breakdown. Here's where we stand now.Jordan Roy-Byrne, CMT is a Chartered Market Technician and member of the Market Technicians Association.. He is the publisher and editor of TheDailyGold Premium, a publication...Read More
The Hydroxy treatment appears to be working so far! In an exclusive interview, Dr. Vladmir Zelenko shares with us a preliminary study outlining that out of his 699 patients treated, he has had ZERO deaths, ZERO intubations, and four hospitalizations. In today's episode of Common Sense, Dr. Zelenko breaks it down and gives a lucid explanation of the rationale behind his treatment. If you have been...Read More